CollPlant

115 articles about CollPlant

• CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant

  9/21/2020

  CollPlant Biotechnologies and United Therapeutics Corporation announced an expansion of their collaboration with the exercise by United Therapeutics of its option to cover a second lifesaving organ, human kidneys.

• CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)

  9/14/2020

  CollPlant has already received first order amounting to hundreds of thousands of U.S. dollars Product distribution in six CIS countries expected to increase clinical use in new patient popu

• CollPlant Biotechnologies to Present at Science of Aging Virtual Symposium 2020 During Healthy Aging Month

  8/31/2020

  CollPlant's photocurable regenerative filler[1] combines the advantages of collagen and hyaluronic acid for skin regeneration

• CollPlant Biotechnologies Reports Second Quarter (Q2) 2020 Financial Results

  8/28/2020

  CollPlant, a regenerative and aesthetics medicine company, announced financial results for the second quarter ended June 30, 2020 and provided an update on the Company's business developments.

• CollPlant Biotechnologies Reports First Quarter (Q1) 2020 Financial Results

  5/27/2020

  CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the first quarter ended March 31, 2020 and provided an update on the Company's business developments. Certain metrics, including those expressed on an adjusted basis, are non-GAAP measures. See "Use of Non-GAAP Measures"

• Collplant to Host Webinar Highlighting its Plant-based, Human Recombinant Collagen (rhCollagen) Platform for the Future of Aesthetic and Regenerative Medicine

  5/5/2020

  CollPlant, a regenerative and aesthetics medicine company, announced that it will be hosting a webinar on Tuesday, May 12, 2020 at 11 am EDT/6 pm IDT that will feature its Co-Founder and Chief Scientist, Professor Oded Shoseyov and Chief Executive Officer, Mr. Yehiel Tal.

• CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments

  2/4/2020

  CollPlant, a regenerative and aesthetic medicine company, announced the launch of its updated corporate website.

• CollPlant Partners in the Advanced Regenerative Manufacturing Institute

  1/6/2020

  CollPlant, a regenerative medicine company, announced it is now part of a new public-private ManufacturingUSA initiative, the Advanced Regenerative Manufacturing Institute.

• CollPlant Publishes Letter to Shareholders - Dec. 19, 2019

  12/19/2019

  CollPlant, a regenerative medicine company, announced that Yehiel Tal, Chief Executive Officer of CollPlant Biotechnologies, has issued a Letter to Shareholders, the full text of which follows below.

• CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update

  11/29/2019

  CollPlant, a regenerative medicine company, announced financial results for the third quarter ended September 30, 2019 and provided an update on the Company's business developments.

• CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee

  10/22/2019

  The Industry Relations Committee represents all aspects of Biofabrication including roadmap, technologies, cell biology, large scale manufacturing, regulation, and commercialization

• CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update

  9/26/2019

  CollPlant, a regenerative medicine company, announced financial results for the second quarter ended June 30, 2019 and provided an update on the Company's business developments.

• CollPlant Biotechnologies Closes on $5.5 Million Financing

  9/9/2019

  Includes $3.5M from group of U.S. accredited investors with deep expertise in 3D printing

• CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference

  9/5/2019

  CollPlant announced that Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on Tuesday, September 10th, 2019 at 1:45 pm EDT.

• CollPlant Biotechnologies Raising $5.5 Million

  9/3/2019

  Investors include CollPlant's largest shareholder and U.S. tech investors

• CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue

  8/5/2019

  CollPlant, a regenerative medicine company, announced that it is developing 3D bioprinted implants for regeneration of breast tissue and has successfully produced first prototypes.

• Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference

  6/4/2019

  CollPlant, a regenerative medicine company, announced that the results from a clinical study conducted with its VergenixFG advanced wound care product will be presented at the 29th Conference of the European Wound Management Association.

• CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update

  5/30/2019

  CollPlant announced financial results for the first quarter ended March 31, 2019 and provided an update on the Company's business developments.

• CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece

  5/28/2019

  CollPlant announced that Dr. Nadav Orr, presented the utilization of CollPlant's recombinant human collagen (rhCollagen) in the field of 3D Bioprinting tissues and organs at the Annual Meeting of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) European Union Chapter in Rhodes, Greece on Monday, May 27, 2019.

• CollPlant Launches New HQ and R&D Center in Israel

  5/22/2019

  CollPlant, a regenerative medicine company, has launched a new HQ and R&D center in Israel.